Concepedia

Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group

Mark A. Morgan, Kathleen M. Darcy, Peter G. Rose, Koen DeGeest, Michael A. Bookman, James K. Aikins, Michael W. Sill, Robert S. Mannel, Cecilia Allievi, Merrill J. Egorin

Gynecologic Oncology · 2008 · 22 citations · 23 references

DOI

Concepts

References

23

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations

, , +17

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Thomas J. Smith, James Khatcheressian, Gary H. Lyman et al. · Journal of Clinical Oncology · 2006 · 1.6K citations · Full text

, , +17

Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies

Tae‐You Kim, Dong-Wan Kim, Jae‐Yong Chung et al. · Clinical Cancer Research · 2004 · 804 citations

, , +14

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Nuhad K. Ibrahim, Neil Desai, Sewa S. Legha et al. · PubMed · 2002 · 630 citations

, , +16